Legislative record
117-HR7658FEDERALIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Latest action: Referred to the House Committee on Energy and Commerce.
Voted 5/3/2022View source